The influence of socio-economic status and multimorbidity patterns on healthcare costs: A six-year follow-up under a universal healthcare system

International Journal for Equity in Health

Volumn 12, Issue 1, 2013, Pages

  Kuo, Raymond N ^a,b   Lai, Mei Shu ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE CLASS; COST-BENEFIT ANALYSIS; DATABASE; DEMOGRAPHY; EMPLOYMENT; HEALTH CARE; HEALTH EXPENDITURE; HEALTH INSURANCE; INCOME DISTRIBUTION; MORBIDITY; PUBLIC HEALTH; SOCIOECONOMIC STATUS;

ADULT; AGED; ARTICLE; DEMOGRAPHY; EMPLOYEE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INCOME; LONGITUDINAL STUDY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NATIONAL HEALTH INSURANCE; OCCUPATION; PARAMEDICAL PERSONNEL; PHYSICIAN; PRIORITY JOURNAL; SELF EMPLOYMENT; SOCIAL STATUS; TAIWAN;

ADULT; AGED; COMORBIDITY; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; SOCIAL CLASS; TAIWAN; YOUNG ADULT;

TAIWAN;

EID: 84883268957     PISSN: None     EISSN: 14759276     Source Type: Journal    
DOI: 10.1186/1475-9276-12-69     Document Type: Article

References (42)

1. Longitudinal administrative data can be used to examine multimorbidity, provided false discoveries are controlled for. Wong A, Boshuizen HC, Schellevis FG, Kommer GJ, Polder JJ, J Clin Epidemiol 2011 64 1109 1117 10.1016/j.jclinepi.2010.12.011 21454049
2. Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Marengoni A, Winblad B, Karp A, Fratiglioni L, Am J Public Health 2008 98 1198 1200 10.2105/AJPH.2007.121137 18511722 (Pubitemid 351947989)
3. Multimorbidity and its measurement. Starfield B, Kinder K, Health Policy 2011 103 3 8 10.1016/j.healthpol.2011.09.004 21963153
4. Aging with multimorbidity: a systematic review of the literature. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L, Ageing Res Rev 2011 10 430 439 10.1016/j.arr.2011.03.003 21402176
5. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, Murphy AW, Fam Pract 2011 28 516 523 10.1093/fampra/cmr013 21436204
6. Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. Laux G, Kuehlein T, Rosemann T, Szecsenyi J, BMC Heal Serv Res 2008 8 http://www.biomedcentral.com/1472-6963/8/ 14/
7. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Wolff JL, Starfield B, Anderson G, Arch Intern Med 2002 162 2269 2276 10.1001/archinte.162.20.2269 12418941 (Pubitemid 35332510)
8. Do lower socioeconomic groups use more health services, because they suffer from more illnesses? Droomers M, Westert GP, European J Public Health 2004 14 311 313 10.1093/eurpub/14.3.311 (Pubitemid 39093630)
9. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B, Lancet 2012 380 37 43 10.1016/S0140- 6736(12)60240-2 22579043
10. Lifecourse socioeconomic circumstances and multimorbidity among older adults. Tucker-Seeley RD, Li Y, Sorensen G, Subramanian SV, BMC Publ Health 2011 11 http://www.biomedcentral.com/1471-2458/11/313
11. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study. Schäfer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A, Gensichen J, Riedel-Heller S, Weyerer S, Blank WA, et al. BMC Heal Serv Res 2012 12
12. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA, BMC Publ Health 2012 12
13. Introduction to the national health insurance research database (NHIRD), taiwan http://w3.nhri.org.tw/nhird/date-01.html
14. Universal coverage under NHI in taiwan http://www.nhi.gov.tw/Resource/ webdata/21717-1-20120808UniversalHealthCoverage.pdf
15. The concepts and principles of equity and health. Whitehead M, Int J Heal Serv 1992 22 429 445 10.2190/986L-LHQ6-2VTE-YRRN (Pubitemid 23364255)
16. Medication, diagnostic, and cost information as predictors of high-risk patients in need of care management. Forrest CB, Lemke KW, Bodycombe DP, Weiner JP, Am J Managed Care 2009 15 41 48
17. Ambulatory care groups-a categorization of diagnoses for research and management. Starfield B, Weiner J, Mumford L, Steinwachs D, Heal Serv Res 1991 26 53 74
18. Health-based risk adjustment: application to premium development and profiling. Tucker A, Weiner J, Abrams C, Financial strategy for managed care organizations: rate setting, risk adjustment, and competitive advantage Chicago: Ill: Health Administration Press, Wrightson CW, 2002 165 225
19. Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan. Kuo RN, Lai MS, BMC Health Serv Res 2010 10 126 10.1186/1472-6963-10-126 20478026
20. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Zhao Y, Ash AS, Ellis RP, Ayanian JZ, Pope GC, Bowen B, Weyuker L, Medical Care 2005 43 34 43 15626932 (Pubitemid 40137612)
21. A comparison of comorbidity measurements to predict healthcare expenditures. Farley JF, Harley CR, Devine JW, Am J Managed Care 2006 12 110 117 (Pubitemid 43256446)
22. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ, Am J Epidemiol 2001 154 854 864 10.1093/aje/154.9. 854 11682368 (Pubitemid 33000813)
23. Common comorbidity scales were similar in their ability to predict health care costs and mortality. Perkins AJ, Kroenke K, Unutzer J, Katon W, Williams JW, Hope C, Callahan CM, J Clin Epidemiol 2004 57 1040 1048 10.1016/j.jclinepi. 2004.03.002 15528055 (Pubitemid 39446643)
24. The medicaid R-x model-pharmacy-based risk adjustment for public programs. Gilmer T, Kronick R, Fishman P, Ganiats TG, Medical Care 2001 39 1188 1202 10.1097/00005650-200111000-00006 11606873 (Pubitemid 33603664)
25. Development of a chronic disease indicator score using a veterans affairs medical center medication database. Malone DC, Billups SJ, Valuck RJ, Carter BL, J Clin Epidemiol 1999 52 551 557 10.1016/S0895-4356(99)00029-3 10408995 (Pubitemid 29281674)
26. Risk adjustment using automated ambulatory pharmacy data-the RxRisk model. Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman DJ, Rosetti MCO, Medical Care 2003 41 84 99 10.1097/00005650-200301000-00011 12544546
27. NEW! ACG RX predictive model http://www.acg.jhsph.edu/ACGDocuments/ ACG%20Rx-PM%20Product%20Sheet.pdf
28. WHO: about the ATC/DDD system http://www.whocc.no/atcddd/
29. Predicting healthcare utilization using a pharmacy-based metric with the WHO's anatomic therapeutic chemical algorithm. Kuo RN, Dong YH, Liu JP, Chang CH, Shau WY, Lai MS, Medical Care 2011 49 1031 1039 10.1097/MLR.0b013e31822ebe11 21945973
30. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H, Annals Family Med 2012 10 142 151 10.1370/afm.1337
31. Multimorbidity-not just an older person's issue. Results from an Australian biomedical study (retracted article. See vol. 46, pg. 351, 2011). Taylor AW, Price K, Gill TK, Adams R, Pilkington R, Carrangis N, Shi ZM, Wilson D, BMC Publ Health 2010 10
32. Multimorbidity in primary care: developing the research agenda. Mercer SW, Smith SM, Wyke S, O'Dowd T, Watt GCM, Fam Pract 2009 26 79 80 10.1093/fampra/cmp020 19287000
33. Prevalence estimates of multimorbidity: a comparative study of two sources. Fortin M, Hudon C, Haggerty J, van den Akker M, Almirall J, BMC Heal Serv Res 2010 10
34. Measures of multimorbidity and morbidity burden for Use in primary care and community settings: a systematic review and guide. Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C, Annals Family Med 2012 10 134 141 10.1370/afm.1363
35. The measurement of multiple chronic diseases-a systematic review on existing multimorbidity indices. Diederichs C, Berger K, Bartels DB, J Gerontol Series a-Biol Sci Med Sci 2011 66 301 311
36. Risk adjustment using administrative data-impact of a diagnosis-type indicator. Ghali WA, Quan H, Brant R, J General Int Med 2001 16 519 524 10.1046/j.1525-1497.2001.016008519.x (Pubitemid 34203390)
37. Validation of diagnostic codes within medical services claims. Wilchesky M, Tamblyn RM, Huang A, J Clin Epidemiol 2004 57 131 141 10.1016/S0895-4356(03) 00246-4 15125622 (Pubitemid 38668607)
38. Marginal impact of psychosocial factors on multimorbidity: results of an explorative nested case-control study. van den Akker M, Buntinx F, Metsemakers JFM, Knottnerus JA, Soc Sci Med 2000 50 1679 1693 10.1016/S0277-9536(99)00408-6 10795973 (Pubitemid 30129140)
39. Socioeconomic-status and health-How education, income, and occupation contribute to risk-factors for cardiovascular-disease. Winkleby MA, Jatulis DE, Frank E, Fortmann SP, Am J Public Health 1992 82 816 820 10.2105/AJPH.82.6.816 1585961
40. Socioeconomic status in health research-one size does not fit all. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S, Jama-J Am Med Assoc 2005 294 2879 2888 10.1001/jama.294.22.2879 (Pubitemid 41785869)
41. Socioeconomic status and health: the role of subjective social status. Demakakos P, Nazroo J, Breeze E, Marmot M, Soc Sci Med 2008 67 330 340 10.1016/j.socscimed.2008.03.038 18440111 (Pubitemid 351787388)
42. Closing the gap in a generation: health equity through action on the social determinants of health. Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S, Hlt CSD, Lancet 2008 372 1661 1669 10.1016/S0140-6736(08)61690-6 18994664